# KUROBE PHARMACEUTICALS, INC.: Form D filing

KUROBE PHARMACEUTICALS, INC., a pharmaceuticals company in Tampa, FL, filed a Form D with the SEC in 2013. The latest, on June 4, 2013, reports $5 million sold of a $6 million offering to 3 investors.

Find out what KUROBE PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20KUROBE%20PHARMACEUTICALS%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=KUROBE%20PHARMACEUTICALS%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fkurobe-pharmaceuticals-inc-1578486)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20KUROBE%20PHARMACEUTICALS%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=KUROBE%20PHARMACEUTICALS%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fkurobe-pharmaceuticals-inc-1578486)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Florida](https://specstream.ai/data/form-d/state/florida): 2,702 rows, by operating companies, filed since November 1, 2024, $107.02, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/florida
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 400 N ASHLEY DRIVE, SUITE 2150, Tampa, FL, 33602
- Phone: (813) 579-2550
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1578486

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 4, 2013 | New notice | $6,000,000 | $5,000,000 | $1,000,000 | 3 | May 21, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1578486/000157848613000001/0001578486-13-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Sean Ianchulev | Director |  |
| BARRY BUTLER | Executive Officer, Director |  |
| Eiji Katayama | Director |  |
| Curt LaBelle | Director |  |
| Yvonne Gallimore | Executive Officer |  |
| Haley Butler | Executive Officer |  |
| Naohito Takahashi | Director |  |

## Other pharmaceuticals companies in Florida that filed recently

- [GOA Therapeutics Corp](https://specstream.ai/data/form-d/company/goa-therapeutics-corp-2131824) $300,000 · Nov 5, 2026
- [DalCor Pharmaceuticals US, LLC](https://specstream.ai/data/form-d/company/dalcor-pharmaceuticals-us-llc-1673368) $7 million · Aug 28, 2026

[Every Form D from the week of Jun 3, 2013](https://specstream.ai/data/form-d/week/2013-06-03) · [All recent filings in Florida](https://specstream.ai/data/form-d/state/florida) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what KUROBE PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).